RUNX1 and acute myeloid leukemia: Thus, both CBF-AML fusion proteins negatively affect both the RUNX1-miR-221-KIT axis and RUNX1-miR-223 transcription, leading to increased KIT-induced proliferation of undifferentiated myeloid cells.